NHS England strikes new deals to make two new innovative treatments available routinely on the NHS

NHS chief Simon Stevens will today announce that NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. From tomorrow (10 November) hundreds of patients with Multiple Sclerosis are set to benefit from a new treatment option, Mavenclad, following a deal with drug company Merck. […]